108 related articles for article (PubMed ID: 4028022)
1. Ability of specific monoclonal antibodies and conventional antisera conjugated to hematoporphyrin to label and kill selected cell lines subsequent to light activation.
Mew D; Lum V; Wat CK; Towers GH; Sun CH; Walter RJ; Wright W; Berns MW; Levy JG
Cancer Res; 1985 Sep; 45(9):4380-6. PubMed ID: 4028022
[TBL] [Abstract][Full Text] [Related]
2. A monoclonal antibody to myelogenous leukemia: isolation and characterization.
Malcolm AJ; Shipman RC; Logan PM; Levy JG
Exp Hematol; 1984 Aug; 12(7):539-47. PubMed ID: 6589167
[TBL] [Abstract][Full Text] [Related]
3. Detection of a common leukemia-associated antigen in human myelogenous leukemia using immunoperoxidase.
Logan PM; Malcolm AJ; Levy JG
Diagn Immunol; 1984; 2(2):86-100. PubMed ID: 6238754
[TBL] [Abstract][Full Text] [Related]
4. Strong, specific anti-human leukemia antisera prepared with the use of purified cell membrane antigen.
Negoro S; Seon BK
Cancer Res; 1981 Jul; 41(7):2973-6. PubMed ID: 6972802
[TBL] [Abstract][Full Text] [Related]
5. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
Raso V; Ritz J; Basala M; Schlossman SF
Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
[TBL] [Abstract][Full Text] [Related]
7. Specific killing of human T-leukemia cells by immunotoxins prepared with ricin A chain and monoclonal anti-human T-cell leukemia antibodies.
Seon BK
Cancer Res; 1984 Jan; 44(1):259-64. PubMed ID: 6606488
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation.
Haynes BF; Hemler M; Cotner T; Mann DL; Eisenbarth GS; Strominger JL; Fauci AS
J Immunol; 1981 Jul; 127(1):347-51. PubMed ID: 6787129
[TBL] [Abstract][Full Text] [Related]
9. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
10. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.
Haynes BF; Bunn P; Mann D; Thomas C; Eisenbarth GS; Minna J; Fauci AS
J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a monoclonal antibody, KR-P8, that detects a new prostate-specific marker.
Raynor RH; Hazra TA; Moncure CW; Mohanakumar T
J Natl Cancer Inst; 1984 Sep; 73(3):617-25. PubMed ID: 6206270
[TBL] [Abstract][Full Text] [Related]
12. Protein-based nanotechnology: antibody conjugated with photosensitizer in targeted anticancer photoimmunotherapy.
Jankun J
Int J Oncol; 2011 Oct; 39(4):949-53. PubMed ID: 21725592
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody against a unique antigen on human acute promyelocytic leukemia cell line (HL-60).
Aota F; Chang D; Hill NO; Khan A
Exp Hematol; 1982 Nov; 10(10):835-43. PubMed ID: 6759147
[TBL] [Abstract][Full Text] [Related]
14. Preliminary studies on a more effective phototoxic agent than hematoporphyrin.
Richter AM; Kelly B; Chow J; Liu DJ; Towers GH; Dolphin D; Levy JG
J Natl Cancer Inst; 1987 Dec; 79(6):1327-32. PubMed ID: 3480384
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
[TBL] [Abstract][Full Text] [Related]
16. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
Ball ED; Graziano RF; Fanger MW
J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
[TBL] [Abstract][Full Text] [Related]
17. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody SN2 defining a human T cell leukemia-associated cell surface glycoprotein.
Seon BK; Negoro S; Barcos MP; Tebbi CK; Chervinsky D; Fukukawa T
J Immunol; 1984 Apr; 132(4):2089-95. PubMed ID: 6607954
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of a unique tumor-associated surface antigen on L1210 leukemia cells recognized by semisyngeneic antisera.
Yokochi T; Kawashima K; Nakashima I; Nagase F; Isobe K; Nagura E; Yamada K; Miyadai T; Kimura Y
Cancer Res; 1987 Feb; 47(4):1006-9. PubMed ID: 3542198
[TBL] [Abstract][Full Text] [Related]
20. Modification of chemotherapeutic effects on L1210 cells using hematoporphyrin and light.
Creekmore SP; Zaharko DS
Cancer Res; 1983 Nov; 43(11):5252-7. PubMed ID: 6616462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
